Seeking Alpha

Alan Robert Ross'  Instablog

Alan Robert Ross
Send Message
I started investing while getting my Ph.D. at McGill University. My research was on behavioral correlates of neurological control of cardiovascular function. After 25 years as a Professor, I quit to do something more exciting and more difficult: live off of my investments. For quite some time, I... More
My company:
Trust Intelligence
My blog:
Trust Intelligence
  • Provectus To List On NYSE? 6 comments
    Jan 20, 2014 4:20 PM

    In the company's latest Presentation

    www.pvct.com/presentation/PVCT_web_prese....pdf

    on page 29 at the bottom, they publicly mention listing on the NYSE for the first time. They have prepared to uplist to the NASDAQ for about a year, and even changed the Directors to comply with Regulations.

    My view is that Provectus wants the widest audience for when it reports the contents of the FDA Minutes and other good news that's on its way, so their priority is speed.

    I think that the Stock Exchange that offers the fastest listing, gets the business. For more details, you can check out the article here:

    www.trustintelligence.com/forum/viewtopi...#p102505

    Disclosure: I am long PVCT, .

Back To Alan Robert Ross' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (6)
Track new comments
  • sheldond
    , contributor
    Comments (994) | Send Message
     
    Sounds good.
    20 Jan, 05:03 PM Reply Like
  • JKenser
    , contributor
    Comments (336) | Send Message
     
    I'd prefer Nasdaq, but it would still be a major move up from OTC land. I would think if they get BTD news than they'll hold out for Nasdaq, as the share price will most certainly rise well above 3 for an extended amount of time.
    20 Jan, 05:32 PM Reply Like
  • Alan Robert Ross
    , contributor
    Comments (409) | Send Message
     
    Author’s reply » Why do you prefer NASDAQ?
    20 Jan, 05:43 PM Reply Like
  • JKenser
    , contributor
    Comments (336) | Send Message
     
    Volume has always been greater in the Nasdaq compared to AMEX/NYSE Mkt. especially when it comes to small cap bio's. Honestly though, if PVCT gets a BTD for PV-10 its probably going to be irrelevant.
    20 Jan, 06:00 PM Reply Like
  • Alan Robert Ross
    , contributor
    Comments (409) | Send Message
     
    Author’s reply » Interesting. I didn't know that.

     

    I prefer the NYSE because it has Specialists versus the NASDAQ where you have a free-for-all with competing and colluding MMs, against the customers.

     

    But the buyers of PVCT stock will happily go to either venue or a third market, compared to the OTC market and there will be more of them because no funds or investors will be restricted due to venue.

     

    And soon it will be marginable, attracting punters, so volume is not a concern of mine.
    20 Jan, 06:23 PM Reply Like
  • sheldond
    , contributor
    Comments (994) | Send Message
     
    My guess is Kenser wants no chance of a reverse split...but either way it is improvement.
    20 Jan, 05:51 PM Reply Like
Full index of posts »
Latest Followers

StockTalks

More »

Latest Comments


Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.